文献速递哮喘

神经介素U介导轻度哮喘气道2型固有淋巴细胞的快速激活

Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

该研究在轻度哮喘受试者(n=8)中开展稀释剂对照过敏原吸入激发试验,发现过敏原激发后7小时痰中表达NMUR1的ILC2显著增加,且多数共表达IL-5/IL-13。NMU/NMUR1轴可快速刺激ILC2分泌2型细胞因子,可能为哮喘嗜酸性炎症的早期激活机制。

要点

  • 过敏原激发后7小时痰NMUR1+ILC2显著增加并共表达IL-5/IL-13。
  • 轻度哮喘痰NMUR1+ILC2计数显著高于中重度哮喘。
  • NMU刺激ILC2的2型细胞因子表达可被地塞米松及MAPK1/2、PI3K抑制剂阻断。

核心结论

  • NMU/NMUR1轴可快速激活ILC2,可能是哮喘嗜酸性炎症反应的早期激活因子。

研究设计与样本

  • 轻度哮喘受试者(n=8)接受稀释剂对照过敏原吸入激发试验。
  • 中重度哮喘受试者(n=9)样本作为对照比较。
  • 采用流式细胞术计数痰ILC2及NMUR1/2型细胞因子表达,ELISA检测气道NMU水平。
  • 分选纯化及体外扩增的ILC2用于功能实验和转录组分析。

主要发现

  • 过敏原激发后7小时痰中表达NMUR1的ILC2较稀释剂激发显著增加,多数NMUR1+ILC2表达IL-5/IL-13。
  • 轻度哮喘痰NMUR1+ILC2计数显著高于中重度哮喘,且在中重度组中与吸入糖皮质激素剂量呈负相关。
  • 与警报素共培养上调ILC2的NMUR1,地塞米松可减弱此上调。
  • NMU刺激ILC2的2型细胞因子表达在6小时达最大,可被地塞米松或MAPK1/2、PI3K特异性信号抑制剂阻断,但IL-33信号分子MyD88抑制剂不能阻断。

临床怎么用

  • NMU/NMUR1轴可能作为哮喘早期嗜酸性炎症的潜在干预靶点。
  • 吸入糖皮质激素可能下调NMUR1+ILC2,支持其抗炎作用机制。

局限性

  • 轻度哮喘样本量较小(n=8),中重度组样本量亦有限(n=9)。
  • 原文未报告研究类型、盲法及具体统计学P值等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: In asthma, sputum group 2 innate lymphoid cells (ILC2s) are activated within 7 hours after allergen challenge. Neuroimmune interactions mediate rapid host responses at mucosal interfaces. In murine models of asthma, lung ILC2s colocalize to sensory neuronal termini expressing the neuropeptide neuromedin U (NMU), which stimulates type 2 (T2) cytokine secretion by ILC2s, with additive effects to alarmins in vitro. Objectives: To investigate the effect of the NMU/NMUR1 (NMU receptor 1) axis on early activation of ILC2s in asthma. Methods: Subjects with mild asthma (n = 8) were enrolled in a diluent-controlled allergen inhalation challenge study. Sputum ILC2 expression of NMUR1 and T2 cytokines was enumerated by flow cytometry, and airway NMU levels were assessed by ELISA. This was compared with samples from subjects with moderate to severe asthma (n = 9). Flow sort-purified and ex vivo-expanded ILC2s were used for functional assays and transcriptomic analyses. Measurements and Main Results: Significant increases in sputum ILC2s expressing NMUR1 were detected 7 hours after allergen versus diluent challenge whereby the majority of NMUR1+ ILC2s expressed IL-5/IL-13. Sputum NMUR1+ ILC2 counts were significantly greater in mild versus moderate to severe asthma, and NMUR1+ ILC2s correlated inversely with the dose of inhaled corticosteroid in the latter group. Coculturing with alarmins upregulated NMUR1 in ILC2s, which was attenuated by dexamethasone. NMU-stimulated T2 cytokine expression by ILC2s, maximal at 6 hours, was abrogated by dexamethasone or specific signaling inhibitors for mitogen-activated protein kinase 1/2 and phosphoinositol 3-kinase but not the IL-33 signaling moiety MyD88 in vitro. Conclusions: The NMU/NMUR1 axis stimulates rapid effects on ILC2s and may be an important early activator of these cells in eosinophilic inflammatory responses in asthma.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Ju X, Nagashima A, Dvorkin-Gheva A, et al. Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma. Am J Respir Crit Care Med. 2024. PMID: 38598774. doi:10.1164/rccm.202311-2164OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。